Integrating genomics with biomarkers and therapeutic targets to invigorate cardiovascular drug development. (2021)

First Author: Holmes MV
Attributed to:  Mendelian randomization to hypothesis-free causal inference funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1038/s41569-020-00493-1

PubMed Identifier: 33707768

Publication URI: http://europepmc.org/abstract/MED/33707768

Type: Journal Article/Review

Volume: 18

Parent Publication: Nature reviews. Cardiology

Issue: 6

ISSN: 1759-5002